BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Lung Cancer
Interventions
DRUG

Erlotinib

Patients will be treated with erlotinib, 150 mg p.o., daily

DRUG

Bevacizumab

Patients will be treated with bevacizumab 15 mg/kg i.v. on day 1 of each 3-week cycle (+/- 3 days)

Trial Locations (48)

1011

Fondation du centre Pluridisciplinaire d'Oncologie (CePO), Lausanne

1211

Geneva University Hospital, Geneva

3010

Inselspital Bern, Bern

3600

Onkologiezentrum Berner Oberland, Thun

4031

University Hospital Basel, Basel

6016

Kantonsspital Luzern, Lucerne

6650

Istituto Oncologica della Svizzera Italiana, Bellinzona

8091

University Hospital Zurich, Zurich

8401

Kantonsspital Winterthur, Winterthur

9007

Kantonsspital St. Gallen, Sankt Gallen

13915

Hôpital de Marseille, Marseille

14000

Centre Francois Baclesse, Caen

17007

ICO - Girona, Girona

20900

Ospedale San Gerardo, Monza

22927

Hospital Grosshansdorf, Großhansdorf

28040

Hospital Clinico Universitario San Carlos, Madrid

28041

Hospital 12 de Octubre, Madrid

35128

Istituto Oncologico Veneto IRCCS, Padua

46014

Hospital General de Valencia, Valencia

46026

Hospital La Fe, Valencia

58675

Lungenklinik Hemer, Hemer

69126

Thoraxklinik Heidelberg GmbH, Heidelberg

89081

Universitätsklinikum Ulm, Ulm

90146

Casa di Cura Maddalena, Palermo

Unknown

University General Hospital of Heraklion, Heraklion

Papageorgias Hospital, Thessaloniki

St Vincent's University Hospital, Dublin

St. James's Hospital, Dublin

University Hospital Galway, Galway

Mid-Western Regional Hospital, Limerick

AMCCH, Tallaght

00133

Policlinico Tor Vergata Roma, Roma

00151

San Camillo Hospital, Roma

00161

Policlinico Umberto, Roma

03010

Hospital General Universitario Alicante, Alicante

08916

ICO - Hospital Universitari Germans Trias i Pujol, Badalona

08025

Hospital De La Santa Creu I Sant Pau, Barcelona

08035

Vall d'Hebron University Hospital, Barcelona

08036

Hospital Clínic Barcelona, Barcelona

08907

ICO - Hospital Duran i Reynals, L'Hospitalet de Llobregat

CM1 7ET

Mid Essex Hospital Services NHS Trust, Chelmsford

DE13 0RB

Queen's Hospital, Burton-on-Trent

LE1 5WW

University Hospitals of Leicester, Leicester

SW3 6JJ

Royal Marsden Hospital, London

ME16 9QQ

Kent Oncology Centre, Maidstone

M20 4BX

Christie Hospital Manchester, Manchester

M23 9LT

Wythenshawe Hospital Manchester, Manchester

LL13 7TD

Wrexham Maelor Hospital, Wrexham

All Listed Sponsors
collaborator

Spanish Lung Cancer Group

OTHER

lead

ETOP IBCSG Partners Foundation

NETWORK

NCT01562028 - BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC) | Biotech Hunter | Biotech Hunter